Overview

  • Product nameAnti-SHC antibody
    See all SHC primary antibodies
  • Description
    Rabbit polyclonal to SHC
  • Tested applicationsSuitable for: WB, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide conjugated to KLH, corresponding to a region within N terminal amino acids 72-101 of Human SHC.

  • Positive control
    • MDA-MB468 cell lysate; Human breast carcinoma

Properties

Applications

Our Abpromise guarantee covers the use of ab103134 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/50 - 1/100. Predicted molecular weight: 63 kDa.
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Target

  • FunctionSignaling adapter that couples activated growth factor receptors to signaling pathways. Participates in a signaling cascade initiated by activated KIT and KITLG/SCF. Isoform p46Shc and isoform p52Shc, once phosphorylated, couple activated receptor tyrosine kinases to Ras via the recruitment of the GRB2/SOS complex and are implicated in the cytoplasmic propagation of mitogenic signals. Isoform p46Shc and isoform p52Shc may thus function as initiators of the Ras signaling cascade in various non-neuronal systems. Isoform p66Shc does not mediate Ras activation, but is involved in signal transduction pathways that regulate the cellular response to oxidative stress and life span. Isoform p66Shc acts as a downstream target of the tumor suppressor p53 and is indispensable for the ability of stress-activated p53 to induce elevation of intracellular oxidants, cytochrome c release and apoptosis. The expression of isoform p66Shc has been correlated with life span (By similarity). Participates in signaling downstream of the angiopoietin receptor TEK/TIE2, and plays a role in the regulation of endothelial cell migration and sprouting angiogenesis.
  • Tissue specificityWidely expressed. Expressed in neural stem cells but absent in mature neurons.
  • Sequence similaritiesContains 1 PID domain.
    Contains 1 SH2 domain.
  • DomainIn response to a variety of growth factors, isoform p46Shc and isoform p52Shc bind to phosphorylated Trk receptors through their phosphotyrosine binding (PID) and/or SH2 domains. The PID and SH2 domains bind to specific phosphorylated tyrosine residues in the Asn-Pro-Xaa-Tyr(P) motif of the Trk receptors. Isoform p46Shc and isoform p52Shc are in turn phosphorylated on three tyrosine residues within the extended proline-rich domain. These phosphotyrosines act as docking site for GRB2 and thereby are involved in Ras activation.
  • Post-translational
    modifications
    Phosphorylated by activated epidermal growth factor receptor. Phosphorylated in response to FLT4 and KIT signaling. Isoform p46Shc and isoform p52Shc are phosphorylated on tyrosine residues of the Pro-rich domain. Isoform p66Shc is phosphorylated on Ser-36 by PRKCB upon treatment with insulin, hydrogen peroxide or irradiation with ultraviolet light (By similarity). Tyrosine phosphorylated in response to FLT3 signaling (By similarity). Tyrosine phosphorylated by activated PTK2B/PYK2 (By similarity). Tyrosine phosphorylated by ligand-activated ALK. Tyrosine phosphorylated by ligand-activated PDGFRB. Tyrosine phosphorylated by TEK/TIE2. May be tyrosine phosphorylated by activated PTK2/FAK1; tyrosine phosphorylation was seen in an astrocytoma biopsy, where PTK2/FAK1 kinase activity is high, but not in normal brain tissue. Isoform p52Shc dephosphorylation by PTPN2 may regulate interaction with GRB2.
  • Cellular localizationCytoplasm; Mitochondrion matrix. Localized to the mitochondria matrix. Targeting of isoform p46Shc to mitochondria is mediated by its first 32 amino acids, which behave as a bona fide mitochondrial targeting sequence. Isoform p52Shc and isoform p66Shc, that contain the same sequence but more internally located, display a different subcellular localization and Mitochondrion. In case of oxidative conditions, phosphorylation at 'Ser-36' of isoform p66Shc, leads to mitochondrial accumulation.
  • Information by UniProt
  • Database links
  • Alternative names
    • FLJ26504 antibody
    • p66 antibody
    • p66SHC antibody
    • SH2 domain protein C1 antibody
    • SHC (Src homology 2 domain containing) transforming protein 1 antibody
    • SHC 1 antibody
    • SHC A antibody
    • Shc antibody
    • SHC transforming protein 1 antibody
    • SHC transforming protein antibody
    • SHC-transforming protein 1 antibody
    • SHC-transforming protein 3 antibody
    • SHC-transforming protein A antibody
    • SHC1 antibody
    • SHC1_HUMAN antibody
    • SHCA antibody
    • Src homology 2 domain-containing-transforming protein C1 antibody
    see all

Anti-SHC antibody images

  • Anti-SHC antibody (ab103134) at 1/50 dilution + MDA-MB468 cell lysate at 35 µg

    Predicted band size : 63 kDa
  • ab103134, at 1/50 dilution, staining SHC in formalin-fixed, paraffin-embedded Human breast carcinoma by Immunohistochemistry using a peroxidase conjugated secondary antibody and DAB staining.

References for Anti-SHC antibody (ab103134)

ab103134 has not yet been referenced specifically in any publications.

Product Wall

Thank you for your email. For activated SHC (66 kDa isoform, phosphorylation on Ser36), we have only 1 antibody: ab54518. It has been tested in WB and with mouse. http://www.abcam.com/shc-phospho-s36-antibody-6e10-ab54518.html For non-activated...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"